Clinical and Microbiological Aspects ofTrichomonas vaginalis
Open Access
- 1 April 1998
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 11 (2), 300-317
- https://doi.org/10.1128/cmr.11.2.300
Abstract
Trichomonas vaginalis, a parasitic protozoan, is the etiologic agent of trichomoniasis, a sexually transmitted disease (STD) of worldwide importance. Trichomoniasis is the most common nonviral STD, and it is associated with many perinatal complications, male and female genitourinary tract infections, and an increased incidence of HIV transmission. Diagnosis is difficult, since the symptoms of trichomoniasis mimic those of other STDs and detection methods lack precision. Although current treatment protocols involving nitroimidazoles are curative, metronidazole resistance is on the rise, outlining the need for research into alternative antibiotics. Vaccine development has been limited by a lack of understanding of the role of the host immune response to T. vaginalis infection. The lack of a good animal model has made it difficult to conduct standardized studies in drug and vaccine development and pathogenesis. Current work on pathogenesis has focused on the host-parasite relationship, in particular the initial events required to establish infection. These studies have illustrated that the pathogenesis of T. vaginalis is indeed very complex and involves adhesion, hemolysis, and soluble factors such as cysteine proteinases and cell-detaching factor. T. vaginalis interaction with the members of the resident vaginal flora, an advanced immune evasion strategy, and certain stress responses enable the organism to survive in its changing environment. Clearly, further research and collaboration will help elucidate these pathogenic mechanisms, and with better knowledge will come improved disease control.Keywords
This publication has 181 references indexed in Scilit:
- Carbohydrate, Energy and Hydrogenosomal Metabolism of Tritrichomonas foetus and Trichomonas vaginalis1The Journal of Protozoology, 1989
- Adherence ofTrichomonas vaginalis to cell culture monolayersEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- 13C‐NMR reveals glycerol as an unexpected major metabolite of the protozoan parasite Trichomonas vaginalisFEBS Letters, 1985
- Pyrimidine metabolism in Trichomonas vaginalisFEBS Letters, 1984
- Lack of Evidence for Cancer Due to Use of MetronidazoleThe New England Journal of Medicine, 1979
- Structure of Trichomonads as Revealed by Scanning Electron Microscopy*†The Journal of Protozoology, 1979
- A new medium for the axenic cultivation of Entamoeba histolytica and other EntamoebaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1978
- Comparative studies on the trichomonacidal activity of 5-nitroimidazole-derivatives in mice infected s.c. or intravaginally with T. vaginalisCellular and Molecular Life Sciences, 1977
- IN VITRO EFFECT OF METRONIDAZOLE ON THE ULTRASTRUCTURE OF TRICHOMONAS VAGINALIS DONNÉActa Pathologica Microbiologica Scandinavica Section B Microbiology, 1976
- ELECTRON MICROSCOPY OF TRICHOMONAS VAGINALIS DONNÉ: INTERACTION WITH VAGINAL EPITHELIUM IN HUMAN TRICHOMONIASISActa Pathologica Microbiologica Scandinavica Section B Microbiology, 1975